Digestive Surgery Division, Department of Gastroenterology, University of São Paulo Medical School (USP), São Paulo, Brazil.
Surgery Department, Paraíba Federal University, João Pessoa, Paraíba, Brazil.
Histol Histopathol. 2021 Feb;36(2):159-181. doi: 10.14670/HH-18-274. Epub 2020 Nov 9.
Resection is the mainstay of treatment for colorectal liver metastases (CRLMs). Many different histopathological factors related to the primary colorectal tumour have been well studied; however, histopathological prognostic factors related to CRLMs are still under evaluation.
To identify histopathological factors related to overall survival (OS) and disease-free survival (DFS) in patients with resected CRLMs.
A systematic review was performed with the following databases up to August 2020: PubMed, EMBASE, Web of Science, SciELO, and LILACS. The GRADE approach was used to rate the overall certainty of evidence by outcome.
Thirty-three studies including 4,641 patients were eligible. We found very low certainty evidence that the following histopathological prognostic factors are associated with a statistically significant decrease in OS: presence of portal vein invasion (HR, 0,50 [95% CI, 0,37 to 0,68]; I²=0%), presence of perineural invasion (HR, 0,55 [95% CI, 0,36 to 0,83]; I²=0%), absence of pseudocapsule (HR, 0,41 [CI 95%, 0,29 to 0,57], p<0,00001; I²=0%), presence of satellite nodules (OR, 0,45 [95% CI, 0,26 to 0,80]; I²=0%), and the absence of peritumoural inflammatory infiltrate (OR, 0,20 [95% CI, 0,08 to 0,54]; I²=0%). Outcome data on DFS were scarce, except for tumour borders, which did not present a significant impact, precluding the meta-analysis.
Of the histopathological prognostic factors studied, low- to moderate-certainty evidence shows that vascular invasion, perineural invasion, absence of pseudocapsule, presence of satellite nodules, and absence of peritumoral inflammatory infiltrate are associated with shorter overall survival in CRLMs.
对于结直肠肝转移(CRLM),切除术是主要的治疗手段。许多与原发结直肠肿瘤相关的不同组织病理学因素已得到充分研究;然而,与 CRLM 相关的组织病理学预后因素仍在评估中。
确定与接受 CRLM 切除术的患者总生存(OS)和无病生存(DFS)相关的组织病理学因素。
系统检索截至 2020 年 8 月的以下数据库:PubMed、EMBASE、Web of Science、SciELO 和 LILACS。采用 GRADE 方法对各结局的证据总体确定性进行评级。
33 项研究纳入了 4641 例患者。我们发现,有非常低确定性证据表明以下组织病理学预后因素与 OS 统计学显著下降相关:门静脉侵犯(HR,0.50 [95%CI,0.37 至 0.68];I²=0%)、神经周围侵犯(HR,0.55 [95%CI,0.36 至 0.83];I²=0%)、无假包膜(HR,0.41 [95%CI,0.29 至 0.57],p<0.00001;I²=0%)、卫星结节(OR,0.45 [95%CI,0.26 至 0.80];I²=0%)和肿瘤周围炎症浸润缺失(OR,0.20 [95%CI,0.08 至 0.54];I²=0%)。DFS 的结局数据很少,除了肿瘤边界,其没有表现出显著的影响,因此排除了荟萃分析。
在所研究的组织病理学预后因素中,低至中确定性证据表明血管侵犯、神经周围侵犯、无假包膜、卫星结节存在以及肿瘤周围炎症浸润缺失与 CRLM 患者的总生存时间较短相关。